Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rishika P. Sakaria has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nasal intermittent positive pressure ventilation in neonates with grade 3 bronchopulmonary dysplasia

    by Mark F. Weems, Vineet Lamba, Sandeep Chilakala, L. Brooke Murdock, Divya Rana, Rishika Sakaria, Parul Zaveri, Rangasamy Ramanathan, Lindsay Burgess, Kristen Dabov, et al.

    Objective: We describe a novel strategy of nasal intermittent positive pressure ventilation (NIPPV) to support patients with Grade 3 bronchopulmonary dysplasia (BPD). Study design: This is a retrospective study of Grade 3 BPD patients treated with NIPPV and discharged from a single center from January 2020 to May 2024. Patients were grouped into discharged without tracheostomy vs with tracheostomy. Groups were assessed for clinical differences, and the NIPPV strategy is described. Results: There were 28 non-tracheostomy and 17 tracheostomy patients. There were no differences in gestational age, birthweight, or respiratory severity score at key dates. Tracheostomy patients were more likely to have subglottic stenosis (53% vs 3.6%, p = 0.0001) and were older at discharge home [median 447 (411–479) vs 252 (184–309) days, p < 0.0001]. Conclusion: A subset of Grade 3 BPD patients can be supported with NIPPV. The non-tracheostomy group had decreased length of stay compared to the tracheostomy group.


  • Open Access

    Changes in cardiorespiratory status after transcatheter patent ductus arteriosus closure

    by Camryn Coley, Rishika Sakaria, Ranjit Philip, Shyam Sathanandam, Mark F. Weems

    Objective: We aim to assess short-term cardiorespiratory outcomes of neonates after transcatheter patent ductus arteriosus (PDA) closure. We hypothesize pre-procedure respiratory severity score (RSS) ≥ 4 is associated with increased risk of post-transcatheter cardiorespiratory syndrome (PTCS). Study design: This was a retrospective study of infants who underwent transcatheter PDA closure from January 2022 to December 2022. Patients were divided by pre-procedure RSS and analyzed for the development of PTCS or hypertensive cardiorespiratory failure. Result: The study included 46 patients with a mean birthweight of 699 g and procedure weight of 1098 g. PTCS was identified in 5 (11%) patients with no differences based on pre-procedure RSS (8 vs 14%, p = 0.66). Post-procedure hypertension was found in 28 (61%) patients (58 vs 64%, p = 0.77), and occurred with respiratory failure in 12 (26%) patients (33 vs 18%, p = 0.32). Conclusion: Pre-procedure RSS was not associated with post-procedure outcomes. While PTCS occurred infrequently, post-procedure hypertension was common.


  • Head Ultrasound Findings in Infants with Birth Weight >1,500 g and Gestational Age >32 Weeks Exposed to Prenatal Opioids

    by Rishika P. Sakaria, Divya Rana, Mimily Harsono, Harris L. Cohen, Massroor Pourcyrous

    This study aimed to evaluate the effects of prenatal exposure to opioids on head ultrasound (HUS) and to determine the need for routine HUS evaluation in infants exposed to prenatal opioids. This is a retrospective cohort study performed at a level III NICU. Infants >32 weeks gestational age and >1,500 g birth weight with prenatal opioid exposure (n = 127) were included in this study. Data including demographic information and HUS results were recorded. Twenty (16%) infants were exposed to opioids only whereas the rest of the infants (84%) were exposed to opioids plus other drugs (polysubstance) in utero. Sixteen of 127 infants (13%) had abnormal initial HUS. Sub-ependymal hemorrhage or grade 1 intraventricular hemorrhage was the most common abnormal finding. Absent septum pellucidum was seen in three infants. A relatively large proportion (13%) of infants in this study had abnormal HUS findings; however, further studies are required to correlate HUS findings with a specific drug of exposure, duration of exposure, polysubstance use, umbilical cord drug concentration levels, and neurodevelopmental outcomes.


  • Open Access

    Chronic Phase Nasal Intermittent Ventilation in Neonates with Grade 3 Bronchopulmonary Dysplasia

    by Mark Weems, Vineet Lamba, Sandeep Chilakala, L. Brooke Murdock, Divya Rana, Rishika Sakaria, Parul Zaveri, Rangasamy Ramanathan

    Objective We describe a novel strategy of chronic-phase nasal intermitted positive pressure ventilation (cNIPPV) to support patients with bronchopulmonary dysplasia (BPD) and avoid tracheostomy. Study Design This is a retrospective study of Grade 3 BPD patients discharged from a single center January 2020 to May 2024. Patients were divided into groups treated with cNIPPV or with tracheostomy. Groups were assessed for clinical differences, and the cNIPPV strategy was described. Result There were 28 cNIPPV and 20 tracheostomy patients. There were no differences between groups for gestational age, birthweight, or respiratory severity score at key dates. Tracheostomy patients were more likely to have subglottic stenosis (55 vs 3.6%, p < 0.0001). Tracheostomy patients were older at discharge home [median 447 (411–514) vs 252 (184–309) days, p < 0.0001]. Conclusion A subset of Grade 3 BPD patients can be supported with cNIPPV and avoid tracheostomy. This strategy may be associated with decreased length of hospital stay.

  • Early Hyperglycemia Is Associated with Increased Incidence of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants

    by Jihan Esmail, Rishika P. Sakaria, Ramasubbareddy Dhanireddy

    Objective Preterm infants have a higher rate of hypoglycemia and hyperglycemia, both of which have been associated with increased neonatal morbidities. The aim of this study was to evaluate the incidence of abnormal glucose homeostasis during the first 72 hours of life and study its association with major morbidities in infants admitted to our neonatal intensive care unit (NICU). Study Design This was a retrospective single-center study. We extracted demographic, maternal, and patient information and blood glucose levels for the first 72 hours of life for all infants with birth weight ≤1,000 g admitted to the NICU from January 2017 to December 2019. Continuous data were presented as mean ± standard deviation or as median with interquartile range. Categorical data were presented as frequency and percentage. Student's t-tests and Mann–Whitney U test were used to analyze continuous data and chi-squared test or Fisher's exact test were used to analyze categorical data. Logistic regression analysis was performed to study the relation between hyperglycemia and various morbidities after controlling for gestational age (GA). Statistical significance was set at p < 0.05. Results Of the 235 infants included in the study, 49% were hypoglycemic at admission to the NICU. Infants that were small for GA and those with history of maternal β-blocker use had a higher incidence of hypoglycemia. Hypoglycemia at admission was not associated with increased mortality or any major morbidities. Seventy-three percent infants who were hypoglycemic or euglycemic at birth developed iatrogenic hyperglycemia during the first 72 hours of life. The incidence of retinopathy of prematurity (ROP) and severe ROP was higher in infants with hyperglycemia on univariate analysis. However, on multivariate analysis, after adjusting for GA, no difference was noted in the incidence of ROP between the two groups. Multivariate analysis could not be performed for severe ROP due to inadequate sample size. Conclusion Hyperglycemia in the initial 3 days of life is associated with an increased incidence of severe ROP in preterm infants. Neonatologists should aim to maintain euglycemia in these infants to decrease the risk of adverse outcomes. Key Points


  • Open Access

    Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

    by Rishika P. Sakaria, Ramasubbareddy Dhanireddy

    Bronchopulmonary Dysplasia (BPD) is a multifactorial disease affecting over 35% of extremely preterm infants born each year. Despite the advances made in understanding the pathogenesis of this disease over the last five decades, BPD remains one of the major causes of morbidity and mortality in this population, and the incidence of the disease increases with decreasing gestational age. As inflammation is one of the key drivers in the pathogenesis, it has been targeted by majority of pharmacological and non-pharmacological methods to prevent BPD. Most extremely premature infants receive a myriad of medications during their stay in the neonatal intensive care unit in an effort to prevent or manage BPD, with corticosteroids, caffeine, and diuretics being the most commonly used medications. However, there is no consensus regarding their use and benefits in this population. This review summarizes the available literature regarding these medications and aims to provide neonatologists and neonatal providers with evidence-based recommendations.


  • Open Access

    Early-Onset Fulminant Sepsis in a Preterm Neonate due to Streptococcus gallolyticus: A Case Report and Literature Review

    by Chandler Williams, Rishika P. Sakaria, Massroor Pourcyrous

    Streptococcus gallolyticus is an uncommon cause of neonatal infections. We describe the first case of fulminant lethal neonatal sepsis due to S. gallolyticus reported in literature. Our patient was an extremely low birth weight premature infant born to a mother with prolonged rupture of amniotic membranes and chorioamnionitis. We also review the cases of neonatal S. gallolyticus infections reported in literature. Fifty-eight percent neonatal S. gallolyticus infections presented in the first week of life. Importantly, S. gallolyticus meningitis is more commonly reported with early-onset infections compared with group B streptococcal meningitis, which is more common with late-onset infections. Streptococcus gallolyticus should be included in differential for neonatal sepsis, particularly in the presence of meningitis in the first week of life. Most cases are sensitive to penicillin; however, cases of reduced sensitivity to penicillin have also been reported.


  • A novel variant in the dystonin gene causing hereditary sensory autonomic neuropathy type VI in a male infant: Case report and literature review

    by Rishika P. Sakaria, Megan P. Fonville, Silpa Peravali, Parul G. Zaveri, Henry J. Mroczkowski, Elena Caron, Mark F. Weems

    The DST gene is located on chromosome 6p and encodes for a large protein. Alternative splicing of this protein produces the neuronal (a1–a3), muscular (b1–b3), and epithelial (e) isoforms. Hereditary sensory and autonomic neuropathy (HSAN) type VI is a rare autosomal recessive disorder due to mutations affecting the a2 isoform. We present a case of HSAN‐VI in a male neonate born to consanguineous parents. Genome sequencing revealed a novel homozygous variant (DST_c.1118C > T; p.Pro373Leu) inherited from both parents. This case further expands the phenotype and genotype of this rare syndrome.


  • Open Access

    Case Report: An Infant With Kabuki Syndrome, Alobar Holoprosencephaly and Truncus Arteriosus: A Case for Whole Exome Sequencing in Neonates With Congenital Anomalies

    by Rishika P. Sakaria, Parul G. Zaveri, Shannon Holtrop, Jie Zhang, Chester W. Brown, Eniko K. Pivnick

    Kabuki syndrome is a rare multiple anomalies syndrome associated with mutations in KMT2D or KDM6A. It is characterized by infantile hypotonia, developmental delay and/or intellectual disability, long palpebral fissures with everted lateral third of the lower eyelids and typical facial features. Intracranial anomalies occur infrequently in patients with KS and holoprosencephaly has only been recently described. Additionally, though congenital heart diseases are common in patients with KS, to our knowledge truncus arteriosus has never been reported in a patient with KS. We present an unusual case of KS in an infant with holoprosencephaly and truncus arteriosus with partial anomalous pulmonary venous return. Duo whole exome sequencing in our patient identified a pathogenic nonsense variant in exon 10 of KMT2D (c.2782C > T; p. Gln928*) establishing the diagnosis. This report further expands the phenotypic spectrum of patients with Kabuki syndrome and emphasizes the utility of performing large scale sequencing in neonates with multiple congenital anomalies.